Haemonetics Corp. (HAE) Misses Q1 EPS by 1c; Affirms FY14 Outlook
Tweet Send to a Friend
Haemonetics Corp. (NYSE: HAE) reported Q1 EPS of $0.46, $0.01 worse ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
